Category | Outcomes |
---|---|
Binary outcome measures | • Primary outcome measure: proportion of patients experiencing an infectious or ischaemic event |
The following secondary outcome measures: | |
• Proportion of patients experiencing an infectious event | |
• Proportion of patients experiencing an ischaemic event | |
• Use of activated factor seven | |
• Use of Human Blood Coagulation Factor IX | |
• Significant pulmonary morbidity | |
Continuous outcome measures | The following secondary outcome measures: |
• Units of RBCs transfused | |
• Fresh frozen plasma transfusions | |
• Cryoprecipitate transfusions | |
• Platelet transfusions | |
Time-to-event outcome measures | The following secondary outcome measures: |
• Time from randomization to first occurrence of the primary outcome measure (secondary analysis of the primary outcome measure) | |
• Duration of post-randomization stay in intensive care or high dependency unit | |
• Duration of post-randomization hospital stay | |
• Time from randomization to death from any cause | |
Continuous longitudinal outcome measures | The following secondary outcome measures: |
• EQ5D single summary index score | |
• EQ5D visual analogue scale score |